Literature DB >> 28257920

A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system.

Sarah Knerr1, Karen J Wernli2, Kathleen Leppig3, Kelly Ehrlich2, Amanda L Graham4, David Farrell5, Chalanda Evans6, George Luta7, Marc D Schwartz6, Suzanne C O'Neill6.   

Abstract

BACKGROUND: Mammographic breast density is one of the strongest risk factors for breast cancer after age and family history. Mandatory breast density disclosure policies are increasing nationally without clear guidance on how to communicate density status to women. Coupling density disclosure with personalized risk counseling and decision support through a web-based tool may be an effective way to allow women to make informed, values-consistent risk management decisions without increasing distress. METHODS/
DESIGN: This paper describes the design and methods of Engaged, a prospective, randomized controlled trial examining the effect of online personalized risk counseling and decision support on risk management decisions in women with dense breasts and increased breast cancer risk. The trial is embedded in a large integrated health care system in the Pacific Northwest. A total of 1250 female health plan members aged 40-69 with a recent negative screening mammogram who are at increased risk for interval cancer based on their 5-year breast cancer risk and BI-RADS® breast density will be randomly assigned to access either a personalized web-based counseling and decision support tool or standard educational content. Primary outcomes will be assessed using electronic health record data (i.e., chemoprevention and breast MRI utilization) and telephone surveys (i.e., distress) at baseline, six weeks, and twelve months. DISCUSSION: Engaged will provide evidence about whether a web-based personalized risk counseling and decision support tool is an effective method for communicating with women about breast density and risk management. An effective intervention could be disseminated with minimal clinical burden to align with density disclosure mandates. Clinical Trials Registration Number:NCT03029286.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast MRI; Breast cancer; Breast density; Chemoprevention; Prevention; Risk communication

Mesh:

Substances:

Year:  2017        PMID: 28257920      PMCID: PMC5473364          DOI: 10.1016/j.cct.2017.02.009

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  56 in total

1.  Chemoprevention of breast cancer: recommendations and rationale.

Authors: 
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

2.  It's Not All About Breast Density: Risk Matters.

Authors:  Nancy C Dolan; Mita Sanghavi Goel
Journal:  Ann Intern Med       Date:  2015-05-19       Impact factor: 25.391

3.  Effects of components of protection-motivation theory on adaptive and maladaptive coping with a health threat.

Authors:  P A Rippetoe; R W Rogers
Journal:  J Pers Soc Psychol       Date:  1987-03

4.  Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results.

Authors:  Suzanne C O'Neill; Tiffani DeMarco; Beth N Peshkin; Sarah Rogers; Jessica Rispoli; Karen Brown; Heiddis Valdimarsdottir; Marc D Schwartz
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-11-15       Impact factor: 3.908

5.  Effects of a psychosocial intervention on breast self-examination attitudes and behaviors.

Authors:  Rachel B Fry; Steven Prentice-Dunn
Journal:  Health Educ Res       Date:  2005-10-21

6.  Committee opinion no. 625: management of women with dense breasts diagnosed by mammography.

Authors: 
Journal:  Obstet Gynecol       Date:  2015-03       Impact factor: 7.661

7.  The density conundrum: does legislation help or hurt?

Authors:  Mary Lou Smith
Journal:  J Am Coll Radiol       Date:  2013-12       Impact factor: 5.532

8.  Prevalence of mammographically dense breasts in the United States.

Authors:  Brian L Sprague; Ronald E Gangnon; Veronica Burt; Amy Trentham-Dietz; John M Hampton; Robert D Wellman; Karla Kerlikowske; Diana L Miglioretti
Journal:  J Natl Cancer Inst       Date:  2014-09-12       Impact factor: 13.506

9.  Patterns of breast magnetic resonance imaging use in community practice.

Authors:  Karen J Wernli; Wendy B DeMartini; Laura Ichikawa; Constance D Lehman; Tracy Onega; Karla Kerlikowske; Louise M Henderson; Berta M Geller; Mike Hofmann; Bonnie C Yankaskas
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

Review 10.  Delivering patient decision aids on the Internet: definitions, theories, current evidence, and emerging research areas.

Authors:  Aubri S Hoffman; Robert J Volk; Anton Saarimaki; Christine Stirling; Linda C Li; Martin Härter; Geetanjali R Kamath; Hilary Llewellyn-Thomas
Journal:  BMC Med Inform Decis Mak       Date:  2013-11-29       Impact factor: 2.796

View more
  7 in total

1.  Randomized Trial of Personalized Breast Density and Breast Cancer Risk Notification.

Authors:  Jennifer S Haas; Catherine S Giess; Kimberly A Harris; Julia Ansolabehere; Celia P Kaplan
Journal:  J Gen Intern Med       Date:  2018-08-08       Impact factor: 5.128

Review 2.  Decision coaching for people making healthcare decisions.

Authors:  Janet Jull; Sascha Köpke; Maureen Smith; Meg Carley; Jeanette Finderup; Anne C Rahn; Laura Boland; Sandra Dunn; Andrew A Dwyer; Jürgen Kasper; Simone Maria Kienlin; France Légaré; Krystina B Lewis; Anne Lyddiatt; Claudia Rutherford; Junqiang Zhao; Tamara Rader; Ian D Graham; Dawn Stacey
Journal:  Cochrane Database Syst Rev       Date:  2021-11-08

3.  Using Protection Motivation Theory to Predict Intentions for Breast Cancer Risk Management: Intervention Mechanisms from a Randomized Controlled Trial.

Authors:  Claire C Conley; Karen J Wernli; Sarah Knerr; Tengfei Li; Kathleen Leppig; Kelly Ehrlich; David Farrell; Hongyuan Gao; Erin J A Bowles; Amanda L Graham; George Luta; Jinani Jayasekera; Jeanne S Mandelblatt; Marc D Schwartz; Suzanne C O'Neill
Journal:  J Cancer Educ       Date:  2021-11-23       Impact factor: 1.771

4.  Prior breast density awareness, knowledge, and communication in a health system-embedded behavioral intervention trial.

Authors:  Siobhan S Mahorter; Sarah Knerr; Erin J Aiello Bowles; Karen J Wernli; Hongyuan Gao; Marc D Schwartz; Suzanne C O'Neill
Journal:  Cancer       Date:  2020-01-24       Impact factor: 6.860

5.  Characteristics Associated with Participation in ENGAGED 2 - A Web-based Breast Cancer Risk Communication and Decision Support Trial.

Authors:  Karen J Wernli; Erin A Bowles; Sarah Knerr; Kathleen A Leppig; Kelly Ehrlich; Hongyuan Gao; Marc D Schwartz; Suzanne C O'Neill
Journal:  Perm J       Date:  2020-12

6.  Effect of a Randomized Trial of a Web-Based Intervention on Patient-Provider Communication About Breast Density.

Authors:  Erin J Aiello Bowles; Suzanne C O'Neill; Tengfei Li; Sarah Knerr; Jeanne S Mandelblatt; Marc D Schwartz; Jinani Jayasekera; Kathleen Leppig; Kelly Ehrlich; David Farrell; Hongyuan Gao; Amanda L Graham; George Luta; Karen J Wernli
Journal:  J Womens Health (Larchmt)       Date:  2021-09-28       Impact factor: 2.681

7.  Effect of Personalized Breast Cancer Risk Tool on Chemoprevention and Breast Imaging: ENGAGED-2 Trial.

Authors:  Karen J Wernli; Sarah Knerr; Tengfei Li; Kathleen Leppig; Kelly Ehrlich; David Farrell; Hongyuan Gao; Erin J A Bowles; Amanda L Graham; George Luta; Jinani Jayasekera; Jeanne S Mandelblatt; Marc D Schwartz; Suzanne C O'Neill
Journal:  JNCI Cancer Spectr       Date:  2021-01-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.